| |
| | HMG-CoA reductase inhibitor mevastatin enhances the growth inhibitory effect of butyrate in the colorectal carcinoma ... |
 | | HMG-CoA reductase inhibitor mevastatin enhances the growth inhibitory effect of butyrate in the colorectal carcinoma cell line Caco-2 -- Wächtershäuser et al. |
 | | Narisawa,T., Morotomi,M., Fukaura,Y., Hasebe,M., Ito,M. and Aizawa,R. (1996) Chemoprevention by pravastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, of N-methyl-N-nitrosourea-induced colon carcinogenesis in F344 rats. |
 | | Lee,S.J., Ha,M.J., Lee,J., Nguyen,P., Choi,Y.H., Pirnia,F., Kang,W.K., Wang,X.F., Kim,S.J. and Trepel,J.B. (1998) Inhibition of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase pathway induces p53-independent transcriptional regulation of p21(WAF1/CIP1) in human prostate carcinoma cells. |
| carcin.oxfordjournals.org /cgi/content/full/22/7/1061 (4309 words) |
|